s.beaulieu
TL2 · Rosario
Contributes reviews on supplier material. Based in Rosario.
Joined 28 February 2025 · last posted 1d
100 posts, newest first. Showing up to 150.
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #109 · Sourcing › Vendor reports · 27 Jul 2026 · 11 likes Comparing your result to somebody else's on a different lot is not a comparison of suppliers. Lot is the unit and it should be in every report. That is the shape of it.…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #108 · Start Here › Welcome · 25 Jul 2026 · 2 likes One small courtesy that makes a large difference: put the specific question in the title. It is the single thing that most changes how quickly you get a useful reply.…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #67 · Clinical › Prescriber conversations · 23 Jul 2026 · 0 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X. On balance I think that is right, and I would not bet…
-
Revisiting: How this community labels and discusses unrefereed work Replied, post #28 · Evidence › Preprints · 18 Jul 2026 · 15 likes The reason community labels is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other is…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #91 · Compounds › Repair & healing peptides · 15 Jul 2026 · 4 likes On post #87 — agreed on the reasoning, with one qualification. Stability of BPC-157 has a well-known answer and a correct answer, and the interesting work is…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #63 · Practice › Dosing & titration · 14 Jul 2026 · 18 likes That matches what I have seen, for whatever a single anecdote is worth.
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #84 · Practice › Interactions · 13 Jul 2026 · 3 likes Adding a data point of agreement rather than a data point.
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #35 · Start Here › Welcome · 12 Jul 2026 · 17 likes Following this. I have the same question and no better information than the first post.
-
What to include when your question involves a chromatogram — one year on Replied, post #73 · Start Here › How to Ask · 12 Jul 2026 · 0 likes Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post, reply. If it is a question that makes sense without the previous…
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #16 · Clinical › Comorbidities · 10 Jul 2026 · 21 likes The failure mode on Osteoarthritis and mechanical versus metabolic is boring rather than dramatic. It is almost always the step everyone assumes was done correctly…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #6 · Access › Insurance & coverage · 7 Jul 2026 · 0 likes Prior authorisation came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
-
Substitution between formats during a shortage — what changed since Started this topic · Access › Shortages · 5 Jul 2026 · 5 likes Substitution between formats during a shortage — what changed since — setting out what I have, and where I think it stops being reliable. What changes if the standard…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #49 · Analytics › Impurities & related substances · 5 Jul 2026 · 0 likes Oxidation at methionine or tryptophan adds sixteen per oxygen and typically elutes earlier. In aged material it is the modification that grows. Filing this under things…
-
Revisiting: Taste changes and food aversion, reported and discussed Replied, post #13 · Practice › Side effects · 2 Jul 2026 · 16 likes The arithmetic in post #10 is right; the assumption feeding it is the part to check. Counterpoint on Taste changes and food aversion, offered without confidence: the…
-
Journal club: what we got wrong in an earlier session Replied, post #31 · Evidence › Journal club · 26 Jun 2026 · 2 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.…
-
Electrolyte supplements: which ones do anything Replied, post #39 · Nutrition & Training › Hydration & electrolytes · 25 Jun 2026 · 12 likes Post #37 describes the usual case. This is about the unusual one. Reading back through the electrolyte supplements threads from last year, the same three questions come…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #46 · Clinical › Bloodwork · 19 Jun 2026 · 0 likes Everything in post #44 holds. The case it does not cover is the one I have. On Liver enzymes drifting, the part that usually goes wrong is that the question is asked as…
-
Preservatives: function, testing, and limits — one year on Replied, post #25 · Pharmacology › Formulation chemistry · 19 Jun 2026 · 23 likes Bulking agents such as mannitol give the cake structure and contribute to the mass in the vial. Their presence is one reason declared fill and peptide content are…
-
Asking a follow-up: new topic or new reply? Replied, post #6 · Start Here › How to Ask · 10 Jun 2026 · 0 likes If the answer you got does not fit your case, say which part does not fit rather than restating the question. Otherwise the next reply is the same as the last one.
-
Tracking a shortage from primary sources rather than rumour Replied, post #34 · Access › Shortages · 3 Jun 2026 · 0 likes Post #32 describes the usual case. This is about the unusual one. Tracking a shortage is one of those subjects where the general answer and the answer for a specific…
-
Sleep apnoea improving and the equipment implications Replied, post #2 · Wellbeing › Sleep · 29 May 2026 · 0 likes That is the distinction I keep failing to hold on to. Written down now.
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #51 · Safety › Contraindications · 26 May 2026 · 26 likes Post #49 describes the usual case. This is about the unusual one. Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to…
-
Prescription requirements and telehealth models — a second dataset Replied, post #33 · Sourcing › Regulatory · 18 May 2026 · 21 likes Nothing in this subcategory is legal advice, and the members who work in regulated environments are the most careful to say so. The literature is thinner on this than…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #112 · Practice › Storage & stability · 8 May 2026 · 0 likes Door storage in a refrigerator is the warmest and most variable position in the appliance. A shelf at the back is a materially different environment.
-
Revisiting: Absolute versus relative contraindications Replied, post #81 · Safety › Contraindications · 3 May 2026 · 10 likes Reading the contraindications section of the actual product information takes two minutes and answers most questions asked here. That holds under the stated conditions…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #79 · Clinical › Bloodwork · 11 Apr 2026 · 1 like Post #77 is the version of this I will quote in future. One addition. A trend needs at least three points to be a trend. Two points are a line and a line through noise…
-
A community side-effect dataset, with its response rate and biases Started this topic · Data & Tools › Datasets · 11 Apr 2026 · 0 likes A community side-effect dataset, with its response rate and biases — setting out what I have, and where I think it stops being reliable. Community side-effect dataset:…
-
Follow-up: State-level differences that actually matter Replied, post #33 · Regional › North America · 5 Apr 2026 · 0 likes Narrowing post #30, because the general version has more than one answer. Worth separating State-level differences as a question about the compound from State-level…
-
Sample handling between despatch and injection Replied, post #19 · Analytics › Method validation · 5 Apr 2026 · 3 likes Where a pharmacopoeial monograph exists, a method that follows it inherits a great deal of assurance. Almost nothing discussed here has one.
-
Whether an aggregate is worth publishing at all: a disputed topic — does this still hold? Replied, post #12 · Data & Tools › Datasets · 31 Mar 2026 · 20 likes Coming back to post #8, because the follow-up matters more than the original answer. Where a value is derived rather than measured, mark it. Derived columns get treated…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #103 · Clinical › Bloodwork · 17 Mar 2026 · 1 like Good question, well framed, and I would like to see it answered properly.
-
Grapefruit: why this class is not the class that cares Replied, post #38 · Practice › Interactions · 14 Mar 2026 · 8 likes Everything in post #35 holds. The case it does not cover is the one I have. Grapefruit was covered in the wiki last year and the page has a review date on it, which is…
-
[2026 update] Composite endpoints and the component doing the work Replied, post #29 · Evidence › Trials · 13 Mar 2026 · 5 likes The thing about Composite endpoints that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.
-
Shoulders, tangent skims, and defensible integration — the long version Replied, post #15 · Analytics › HPLC & UHPLC · 6 Mar 2026 · 2 likes Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and eluted by increasing organic solvent. For peptides the mobile…
-
Publication bias detection and its low power — does this still hold? Replied, post #15 · Evidence › Meta-analyses · 3 Mar 2026 · 25 likes Marking my uncertainty on Publication bias detection explicitly. I am confident about the direction, much less confident about the size, and not confident at all that…
-
Choosing which test to pay for, given a fixed budget Replied, post #11 · Sourcing › Independent verification · 2 Mar 2026 · 0 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #132 · Compounds › Semaglutide · 1 Mar 2026 · 16 likes Adding the measurement that post #131 says would settle it. Injection site does not appear to matter much for semaglutide exposure. The published comparisons of…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #90 · Access › International · 4 Feb 2026 · 4 likes Language barriers in accessing: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I…
-
Reading U-100 graduations, with a conversion table — one year on Replied, post #3 · Devices › Syringes & needles · 25 Jan 2026 · 1 like Answering the question the opening post raises rather than the one it answers. Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL.…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #51 · Meta › Site feedback · 22 Jan 2026 · 20 likes Topic list: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would like to know…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #72 · Practice › Side effects · 19 Jan 2026 · 1 like Post #70 describes the usual case. This is about the unusual one. A request rather than an answer: could whoever has the primary source for muscle cramps post it? I…
-
Preprint servers and what screening they do Replied, post #20 · Evidence › Preprints · 10 Jan 2026 · 0 likes Clear enough that I do not think I have a follow-up, which is unusual.
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #121 · Compounds › Oral incretins · 31 Dec 2025 · 12 likes Post #118 is the version of this I will quote in future. One addition. SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an absorption enhancer that…
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #25 · Start Here › Welcome · 28 Dec 2025 · 16 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
The decimal-point error, and the habit that catches it Replied, post #107 · Practice › Reconstitution · 18 Dec 2025 · 18 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
CJC-1295 with and without DAC: what the modification does — what changed since Replied, post #3 · Compounds › Secretagogues & GH axis · 13 Dec 2025 · 8 likes GHRH analogues versus ghrelin mimetics are often conflated but they are different mechanisms. GHRH analogues (like CJC-1295) cause the pituitary to release growth…
-
Tracking a preprint to publication: a worked example Replied, post #124 · Evidence › Preprints · 12 Dec 2025 · 5 likes Useful. I have added it to my own notes with the date on it.
-
Tracking a preprint to publication: a worked example Replied, post #40 · Evidence › Preprints · 3 Dec 2025 · 8 likes Author track record is a weak signal and it is a signal. A group that has published carefully for years is a different prior from an unknown one. I would hold that…
-
Follow-up: What a statistical analysis plan adds that the paper does not Started this topic · Evidence › Trials · 30 Nov 2025 · 7 likes What a statistical analysis plan adds that the paper does not I have a specific reason for asking rather than idle curiosity, and the context is below. A follow-up…
-
What a purity-only report leaves out Replied, post #100 · Sourcing › Independent verification · 24 Nov 2025 · 6 likes I would rather this thread reach "we do not know" about purity-only than reach a confident answer that nobody can support when asked.
-
Pen dose counters: what a click does and does not guarantee Replied, post #74 · Devices › Pens & autoinjectors · 17 Nov 2025 · 15 likes Adding the measurement that post #72 says would settle it. Travel with a pen raises a cold-chain question and a documentation question. The second is the one people…
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #76 · Analytics › HPLC & UHPLC · 4 Nov 2025 · 19 likes Adding the measurement that post #73 says would settle it. The thing about detection wavelength that took me longest to accept is that a plausible mechanism is not…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #101 · Practice › Storage & stability · 24 Oct 2025 · 0 likes Adding the measurement that post #100 says would settle it. Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or…
-
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #3 · Outcomes › Body composition · 5 Oct 2025 · 0 likes Percentage body fat is a ratio, so it changes when either component changes. A rising percentage during weight loss is arithmetic before it is physiology.
-
A payment that went through twice: how it was resolved Replied, post #5 · Sourcing › Payments · 4 Oct 2025 · 2 likes I read the opening post twice before replying, because I had assumed the opposite. Chargeback reality: if you pay by credit card and the supplier does not deliver, you…
-
MHRA statements, read directly Replied, post #6 · Regional › UK & Ireland · 21 Sep 2025 · 7 likes Where the MHRA statements discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same sentence…
-
Payment method and the leverage it gives you, ranked Replied, post #21 · Sourcing › Payments · 16 Sep 2025 · 21 likes Marking my uncertainty on payment method explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #115 · Evidence › Study critique · 16 Sep 2025 · 13 likes A definition problem is doing most of the work in this Reverse causation discussion. Once the term is pinned down I suspect the disagreement mostly goes away and what…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #119 · Practice › Reconstitution · 5 Sep 2025 · 0 likes On 10 mg vial reconstituted three I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #86 · Compounds › Oral incretins · 21 Aug 2025 · 0 likes Where I part company with post #84, and it is a narrow parting. Dose equivalence between oral and injectable formulations is not a simple conversion and no published…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #44 · Practice › Side effects · 20 Aug 2025 · 2 likes Confirming post #42 from a second method, which matters more than confirming it from a second person. Fatigue: commonly reported, frequently multifactorial. It is worth…
-
Why most self-reports here are not experiments, and that is fine Started this topic · Research Methods › N-of-1 designs · 17 Aug 2025 · 13 likes Why most self-reports here are not experiments, and that is fine — that is the question, and I have not found it answered plainly anywhere I have looked. A question…
-
Publishing an inconvenient result: a case study Replied, post #64 · Sourcing › Independent verification · 11 Aug 2025 · 0 likes The reason publishing an inconvenient result keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer…
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #38 · Compounds › Retatrutide · 7 Aug 2025 · 22 likes Narrowing post #35, because the general version has more than one answer. A theoretical mass for retatrutide is not published in the peer-reviewed literature in a form…
-
Are there stupid questions here? A staff answer, at length Replied, post #41 · Start Here › Welcome · 5 Aug 2025 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Tracking that stops updating and then resumes Replied, post #15 · Sourcing › Logistics · 4 Aug 2025 · 0 likes Split shipments reduce single-point risk and increase the number of transits. Which trade is right depends on what you are protecting against. The short version is the…
-
Travel coolers and how long they really hold Replied, post #24 · Devices › Cold chain · 2 Aug 2025 · 19 likes The honest summary: pack quality is visible, transit history is not, and only the second determines what happened to the material.
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #78 · Compounds › Repair & healing peptides · 2 Aug 2025 · 0 likes The preclinical work is genuinely interesting and it is preclinical. A rodent tendon model is a model of a rodent tendon, and the translation record from that kind of…
-
Realistic expectations for strength while losing weight quickly Replied, post #11 · Nutrition & Training › Resistance training · 2 Aug 2025 · 22 likes Answering the question post #9 raises rather than the one it answers. Reduced appetite makes fuelling a session harder, and that is a practical problem with practical…
-
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #37 · Compounds › Cagrilintide & amylin analogues · 9 Jul 2025 · 10 likes I read post #35 twice before replying, because I had assumed the opposite. The version of Nausea profile of amylin analogues that circulates here is a simplification of…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #55 · Evidence › Journal club · 26 Jun 2025 · 1 like Taking post #54 at face value and following it one step further. The summary that goes to the digest should say what the paper establishes, what it does not, and one…
-
Regression to the mean in progress reports Replied, post #22 · Research Methods › Statistics · 19 Jun 2025 · 14 likes I read post #18 twice before replying, because I had assumed the opposite. Posting my regression numbers with the method attached so they can be discounted properly.…
-
A report I filed that turned out to be wrong, and the correction Replied, post #109 · Sourcing › Vendor reports · 18 Jun 2025 · 3 likes Taking post #107 at face value and following it one step further. Date the report: when the analysis was done matters. Material can degrade in storage. A report from…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #12 · Documentation › Doc review · 13 Jun 2025 · 0 likes Since Promotion criteria keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct…
-
Preparing for an appointment: one page, three questions Replied, post #22 · Clinical › Prescriber conversations · 9 Jun 2025 · 13 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X.
-
An emergency department visit, described afterwards Replied, post #28 · Safety › Adverse events · 6 Jun 2025 · 2 likes Injection-site reactions that spread over a day or come with systemic symptoms are a different observation from ordinary local reactions. One case, stated as one case.
-
Albumin binding and how it produces a long half-life Replied, post #35 · Pharmacology › Pharmacokinetics · 12 May 2025 · 4 likes The arithmetic in post #34 is right; the assumption feeding it is the part to check. One more thing on albumin binding that took me far too long to see: the two figures…
-
A well-designed study with a badly written abstract Replied, post #63 · Evidence › Study critique · 5 May 2025 · 0 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
Cost per milligram, computed honestly across formats — the long version Replied, post #57 · Access › Pricing · 7 Apr 2025 · 26 likes Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a lower tier usually requires prior authorization or documented…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #24 · Compounds › Tirzepatide · 12 Mar 2025 · 0 likes Post #23 answers the question as asked. The question underneath it is different. Heart rate rises modestly across this class, tirzepatide included. It is consistent,…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #120 · Compounds › Semaglutide · 4 Mar 2025 · 0 likes I read post #118 twice before replying, because I had assumed the opposite. On Semaglutide half-life I would separate what is worth knowing from what is worth acting…
-
What we do not know about retatrutide, listed explicitly Replied, post #62 · Compounds › Retatrutide · 19 Jan 2025 · 22 likes Building on post #60 rather than restating it. Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is…
-
When a preprint is the best available evidence and we say so — a second dataset Replied, post #11 · Evidence › Preprints · 19 Jan 2025 · 0 likes Where a preprint contradicts a published trial, the prior should favour the trial. Where it extends one, the preprint can be genuinely useful.
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #5 · Compounds › Repair & healing peptides · 10 Jan 2025 · 7 likes A note on scope: what I am saying about BPC-157 applies to the case in the first post and I would not extend it further without checking.
-
[2026 update] New subcategory: rationale and scope Replied, post #135 · Meta › Announcements · 9 Jan 2025 · 3 likes Everything in post #134 holds. The case it does not cover is the one I have. Careful with the language on New subcategory. "Not detected" and "not present" are…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #15 · Practice › Reconstitution · 27 Dec 2024 · 3 likes Post #14 answers the question as asked. The question underneath it is different. Nobody has said the unglamorous part of reconstituting a multi-strength kit yet, so:…
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #2 · Compounds › Secretagogues & GH axis · 23 Dec 2024 · 7 likes The opening post put the caveat in the right place and I want to underline it. Well-designed human trial is well covered in the tag pages, and the older discussions are…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #14 · Data & Tools › Calculators · 9 Dec 2024 · 0 likes Precision and significant figures: the calculators do not round to match your input precision. If you input values to one decimal place, the output might have more. Use…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #45 · Compounds › Tirzepatide · 20 Nov 2024 · 0 likes I had written a reply contradicting post #43 and deleted it. Here is what survived. Categorical response thresholds — the proportion reaching ten, fifteen or twenty per…
-
Transporting a vial for a weekend away Replied, post #25 · Practice › Storage & stability · 2 Nov 2024 · 0 likes Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later need to know whether it has been sitting for weeks or days, the…
-
Second pass at: Buffers, pH and why a formulation is a formulation Replied, post #15 · Pharmacology › Formulation chemistry · 24 Oct 2024 · 2 likes Two people in this thread mean different things by Buffers and are disagreeing about the definition while believing they are disagreeing about the facts. Worth pausing…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #28 · Compounds › Semaglutide · 19 Oct 2024 · 4 likes Where I part company with post #24, and it is a narrow parting. Albumin binding is not a unique structural feature and nothing in the class lacks it, but the…
-
Blind submission and why it changes minds Replied, post #91 · Sourcing › Independent verification · 18 Oct 2024 · 8 likes My understanding of blind submission is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating it.
-
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #7 · Compounds › Retatrutide · 28 Aug 2024 · 0 likes This is the sort of exchange that makes the archive worth searching.
-
Why I ask for the gradient before I discuss the number Replied, post #11 · Analytics › HPLC & UHPLC · 5 Aug 2024 · 14 likes Taking post #8 at face value and following it one step further. Detection at 214 nanometres sees the peptide bond and therefore sees almost everything peptidic. At 280…
-
Guidelines revision: what changed and why Replied, post #127 · Meta › Announcements · 28 Jul 2024 · 2 likes Taking post #126 at face value and following it one step further. The confident answers on guidelines revision and the well-sourced answers are not the same answers,…
-
The mass-error checker and its intended scope Replied, post #156 · Data & Tools › Calculators · 26 Jul 2024 · 0 likes Post #154 is the version of this I will quote in future. One addition. Second-hand on mass-error checker, so weight it accordingly — someone whose method I trust told…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #102 · Compounds › Retatrutide · 23 Jul 2024 · 0 likes On dose escalation: the published protocols escalated in defined steps over defined intervals, and those intervals were chosen to manage tolerability. Compressing them…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #15 · Practice › Dosing & titration · 6 Jul 2024 · 0 likes I had read the opposite somewhere and cannot now find where, which tells me something.
-
Cold packs, phase-change material, and what survives ten days Replied, post #5 · Sourcing › Logistics · 10 Jun 2024 · 13 likes The reason cold packs is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other is silent.